The study found that TET has mutations in a variety of tumors, and the highest mutation rate in this study is TET1, which has repeated mutations in a variety of cancers and is more common in skin cancer, lung cancer, gastrointestinal cancer, and urogenital cancer. Here, TET1 is linked to lung carcinoma.